BenchSci Company

BenchSci uses AI to empower scientists to run more successful experiments to accelerate drug discovery. BenchSci's vision is to bring medicine to patients 50% faster by 2025. The company empowers scientists with the world’s most advanced biomedical artificial intelligence to run more successful experiments. Backed by F-Prime, Gradient Ventures (Google’s AI fund), and Inovia Capital, BenchSci's proprietary technology accelerates science at 15 top 20 pharmaceutical companies and over 4,300 leading research centers worldwide. BenchSci is a CIX Top 10 Growth company, certified Great Place to Work, and top-ranked company on Glassdoor.
Technology: Artificial Intelligence, Biotechnology, Life Science, Machine Learning, Pharmaceutical
Industry: Early Drug Development
Headquarters: Toronto, Ontario, Canada
Founded Date: 2015-01-01
Employees Number: 101-250
Funding Status: Late Stage Venture
Investors Number: 14
Total Funding: 94533057
Estimated Revenue: Less than $1M
Last Funding Date: 2022-01-24
Last Funding Type: Series C

Visit Website
simon@benchsci.com
https://www.twitter.com/benchsci
Register and Claim Ownership